Exelixis (EXEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Leerink Partners analyst Andrew Berens has maintained their neutral stance on EXEL stock, giving a Hold rating today. Andrew Berens has given ...

RBC Capital analyst Gregory Renza maintained a Buy rating on Exelixis (EXEL – Research Report) yesterday and set a price target of ...

A federal judge in Delaware has ruled in favor of Exelixis in its Cabometyx patent fight with MSN Laboratories, effectively ...

The Delaware District Court ruled in EXEL's favor, rejecting MSN's challenge to three patents related to cabozantinib.

Exelixis, Inc. (NASDAQ:EXEL – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday after Bank of America raised their price target on the stock from $30.00 to ...

Small- and mid-cap stocks are poised to surpass large caps atop markets. BMO's strategy chief shared 17 stocks to buy during ...

Paige Mahaney, Ph.D. Chief Scientific Officer Mahaney Brings More Than 25 Years of Pharmaceutical and Biotech Experience ...

The valuation backdrop for small- and mid-caps continue to look compelling for investors looking to add exposure, said BMO Capital Markets' Brian G. Belski.

Konica Minolta, Inc. (OTCMKTS:KNCAF – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling ...

Merck (NYSE:MRK) announced Thursday that its 21-valent pneumococcal vaccine, Capvaxive, approved in the U.S. to prevent ...

Indian benchmark indices Nifty 50 and Sensex ended lower in the previous trade session. Nifty 50 closed at 25,057.35, while Sensex ended at 81,820.12. Overnight, Wall Street indices tumbled from ...